Bill Search

SB 188
  • Introduced
    Feb 24, 2022
  • Passed Senate
  • Passed House
  • Signed into Law
SB 188
Connecticut Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
AN ACT REQUIRING BRAND NAME PRESCRIPTION DRUG MANUFACTURERS TO PROVIDE SAMPLES OF BRAND NAME DRUGS TO GENERIC PRESCRIPTION DRUG MANUFACTURERS. To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
Last Action See all actions
Senate • Apr 07, 2022: Referred by Senate to Committee on Judiciary
Latest Bill Text See all bill texts
File No. 214

Official Summary/Bill Text

Comments on SB 188

Tweets

Whip Lists

Sponsors
Votes
Mar 15, 2022, Senate
GL Vote Tally Sheet (Joint Favorable)
YES: 11
NO: 7
OTHER: 1
YES: 11

NO: 7

ABSENT: 1

Sources
Actions
  • Apr 07, 2022 | Senate
    • Referred by Senate to Committee on Judiciary
  • Mar 30, 2022 | Senate
    • Reported Out of Legislative Commissioners' Office (LCO)
    • Favorable Report, Tabled for the Calendar, Senate
    • Senate Calendar Number 170
    • File Number 214 (LCO)
  • Mar 24, 2022 | Senate
    • Referred to Office of Legislative Research and Office of Fiscal Analysis 03/29/22 5:00 PM (LCO)
  • Mar 16, 2022 | Senate
    • Filed with Legislative Commissioners' Office (LCO)
  • Mar 15, 2022 | Senate
    • Joint Favorable (GL)
  • Feb 25, 2022 | Senate
    • Public Hearing 03/01
  • Feb 24, 2022 | Senate
    • Referred to Joint Committee on General Law
Bill Texts
Documents
Sources